Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$254M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| PISKEL KYLE | Nov 18, 2024 | Sell | 248 | $4.98 | $1,200 |
| Taylor Stacy L | Aug 22, 2024 | Sell | 26,922 | $4.4974 | $120,000 |
| LO FRANCIS | Mar 5, 2024 | Sell | 12,887 | $3.43 | $44,000 |
| BENZENO SHARON | Mar 5, 2024 | Sell | 18,644 | $3.44 | $64,000 |
| BENZENO SHARON | Mar 5, 2024 | Sell | 10,746 | $3.43 | $37,000 |
| RUBINSTEIN JULIE | Mar 5, 2024 | Sell | 25,580 | $3.43 | $88,000 |
| RUBINSTEIN JULIE | Mar 5, 2024 | Sell | 13,490 | $3.56 | $48,000 |
| PETERSON TYCHO | Mar 5, 2024 | Sell | 15,456 | $3.44 | $53,000 |
| ROBINS CHAD M | Mar 5, 2024 | Sell | 42,794 | $3.43 | $150,000 |
| PISKEL KYLE | Mar 5, 2024 | Sell | 7,727 | $3.43 | $27,000 |
| Taylor Stacy L | Mar 5, 2024 | Sell | 6,772 | $3.43 | $23,000 |
| Taylor Stacy L | Mar 5, 2024 | Sell | 6,609 | $3.44 | $23,000 |
| LO FRANCIS | Mar 5, 2024 | Sell | 1,813 | $3.44 | $6,200 |
| ROBINS CHAD M | Mar 5, 2024 | Sell | 5,879 | $3.44 | $20,000 |
| BOBULSKY SUSAN | Mar 5, 2024 | Sell | 6,975 | $3.44 | $24,000 |
| BOBULSKY SUSAN | Mar 5, 2024 | Sell | 6,016 | $3.43 | $21,000 |
| PISKEL KYLE | Nov 16, 2023 | Sell | 259 | $4.13 | $1,100 |
| SOOD NITIN | Aug 8, 2023 | Sell | 10,550 | $6.54 | $69,000 |
| SOOD NITIN | Aug 7, 2023 | Sell | 5,652 | $6.78 | $38,000 |
| PETERSON TYCHO | Jun 20, 2023 | Sell | 70,000 | $8.14 | $570,000 |
| PETERSON TYCHO | Jun 20, 2023 | Sell | 64,961 | $8.14 | $530,000 |
| PETERSON TYCHO | Jun 15, 2023 | Sell | 55,672 | $8.53 | $470,000 |
| PETERSON TYCHO | Jun 15, 2023 | Sell | 14,328 | $8.53 | $120,000 |
| PETERSON TYCHO | Jun 2, 2023 | Sell | 38,000 | $7.16 | $270,000 |
| ADAMS R MARK | Apr 11, 2023 | Sell | 2,308 | $8.63 | $20,000 |
| ADAMS R MARK | Apr 10, 2023 | Sell | 817 | $8.5 | $6,900 |
| GRIFFIN MICHELLE RENEE | Mar 27, 2023 | Sell | 2,341 | $8.4913 | $20,000 |
| Taylor Stacy L | Mar 7, 2023 | Sell | 13,387 | $8.6 | $120,000 |
| ADAMS R MARK | Mar 7, 2023 | Sell | 17,155 | $8.6 | $150,000 |
| SOOD NITIN | Mar 7, 2023 | Sell | 9,813 | $8.6 | $84,000 |
| BENZENO SHARON | Mar 6, 2023 | Sell | 11,749 | $8.57 | $100,000 |
| RUBINSTEIN JULIE | Mar 6, 2023 | Sell | 22,668 | $8.57 | $190,000 |
| PISKEL KYLE | Mar 6, 2023 | Sell | 3,300 | $8.57 | $28,000 |
| LO FRANCIS | Mar 6, 2023 | Sell | 6,816 | $8.57 | $58,000 |
| Taylor Stacy L | Mar 6, 2023 | Sell | 5,491 | $8.57 | $47,000 |
| ADAMS R MARK | Mar 6, 2023 | Sell | 6,529 | $8.57 | $56,000 |
| SOOD NITIN | Mar 6, 2023 | Sell | 6,661 | $8.57 | $57,000 |
| PISKEL KYLE | Mar 6, 2023 | Sell | 229 | $8.58 | $2,000 |
| ADAMS R MARK | Jan 10, 2023 | Sell | 2,130 | $8.58 | $18,000 |
| ADAMS R MARK | Jan 9, 2023 | Sell | 995 | $8.5 | $8,500 |
What's the latest insider transaction for Adaptive Biotechnologies?
The most recent insider transaction for Adaptive Biotechnologies was conducted by PISKEL KYLE, who sold 248 shares on November 18, 2024 at a price of $4.98 per share.
Which insider has sold the most ADPT stock over the last two years?
PETERSON TYCHO has sold the most ADPT stock in the last 2 years, with a total value of $2M.
What is the total value of insider transactions for Adaptive Biotechnologies (ADPT) in the last 2 years?
The total value of insider transactions for Adaptive Biotechnologies in the last 2 years is negative, amounting to -$3.8M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Adaptive Biotechnologies' market confidence?
Over the last 2 years, insider transactions for Adaptive Biotechnologies have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
